Holen Sie sich die Stockscreener-App
16.13
4.54%
0.7026
Schlusskurs vom Vortag:
$15.43
Offen:
$15.43
24-Stunden-Volumen:
810.04K
Relative Volume:
0.46
Marktkapitalisierung:
$1.84B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-284.08M
KGV:
-9.0633
EPS:
-1.78
Netto-Cashflow:
$-234.65M
1W Leistung:
+3.53%
1M Leistung:
+29.98%
6M Leistung:
+231.21%
1J Leistung:
+38.22%
1-Tages-Spanne:
$15.26
$16.38
1-Wochen-Bereich:
$15.26
$16.99
52-Wochen-Spanne:
$3.72
$16.99
Cogent Biosciences Inc Stock (COGT) Company Profile
Firmenname
Cogent Biosciences Inc
Sektor
Branche
Telefon
617-945-5576
Adresse
275 WYMAN STREET, WALTHAM
Vergleichen Sie COGT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COGT
Cogent Biosciences Inc
|
16.14 | 2.16B | 0 | -284.08M | -234.65M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.91 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.42 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
581.62 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
818.25 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.77 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cogent Biosciences Inc Stock (COGT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Eingeleitet | Raymond James | Strong Buy |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-12-11 | Herabstufung | Needham | Buy → Hold |
| 2024-02-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-02-08 | Eingeleitet | Citigroup | Buy |
| 2023-12-11 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-12-08 | Eingeleitet | JP Morgan | Overweight |
| 2023-04-28 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-03-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-12-14 | Eingeleitet | Needham | Buy |
| 2022-06-28 | Eingeleitet | Guggenheim | Buy |
| 2021-10-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-06-09 | Fortgesetzt | Jefferies | Buy |
| 2020-12-23 | Eingeleitet | Piper Sandler | Overweight |
| 2020-10-14 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Cogent Biosciences Inc Aktie (COGT) Neueste Nachrichten
How strong is Cogent Biosciences Inc. stock revenue growth2025 Volume Leaders & Fast Entry Momentum Alerts - newser.com
Is Cogent Biosciences Inc. stock a buy before product launchesJuly 2025 Sentiment & AI Driven Stock Price Forecasts - newser.com
13 Biotech Stocks Charging Ahead With New 52-week HighsWill Near-term Catalysts Drive More Gains? - RTTNews
Relative strength of Cogent Biosciences Inc. in sector analysisInsider Selling & Free Daily Entry Point Trade Alerts - newser.com
Momentum divergence signals in Cogent Biosciences Inc. chartJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com
Cogent Biosciences Soars to 52-Week High on "Breakthrough" Systemic Mastocytosis Trial Results - FinancialContent
Cogent Biosciences (NASDAQ:COGT) Reaches New 1-Year HighWhat's Next? - MarketBeat
Cogent Biosciences stock hits 52-week high at 16.49 USD - Investing.com
Will Cogent Biosciences Inc. stock outperform tech sector in 2025Weekly Earnings Recap & Verified Momentum Stock Alerts - newser.com
Volume spikes in Cogent Biosciences Inc. stock – what they meanJuly 2025 Big Picture & Smart Investment Allocation Tips - newser.com
Will Cogent Biosciences Inc. stock split attract more investorsJuly 2025 Outlook & Intraday High Probability Setup Alerts - newser.com
Sentiment analysis tools applied to Cogent Biosciences Inc.Trade Volume Report & Real-Time Buy Zone Alerts - newser.com
Cogent Biosciences, Inc. (COGT): Analyst Ratings Point To A Promising 30% Upside - DirectorsTalk Interviews
Will earnings trigger a reversal in Cogent Biosciences Inc.Dividend Hike & Stepwise Swing Trade Plans - newser.com
Visual trend scoring systems applied to Cogent Biosciences Inc.July 2025 Patterns & Fast Moving Trade Plans - newser.com
Cogent Biosciences (NASDAQ:COGT) Given Sell (E+) Rating at Weiss Ratings - MarketBeat
Cogent Biosciences Inc. stock outlook for YEARJuly 2025 Catalysts & Weekly Setup with ROI Potential - newser.com
Cogent Biosciences (NASDAQ:COGT) Hits New 52-Week HighHere's Why - MarketBeat
Historical volatility pattern of Cogent Biosciences Inc. visualizedEarnings Risk Report & High Yield Stock Recommendations - newser.com
Is Cogent Biosciences Inc a good long term investmentEx-Dividend Date Alerts & Rapid Wealth Accumulation - earlytimes.in
Published on: 2025-10-05 05:47:04 - newser.com
When is the best time to exit Cogent Biosciences Inc.CEO Change & Daily Entry Point Alerts - newser.com
Cogent Biosciences Relocates Headquarters to BXP’s 180 CityPoint - Connect CRE
Cogent Biosciences patents new GTPase KRAS inhibitors - BioWorld MedTech
Published on: 2025-10-03 00:35:36 - newser.com
Is Cogent Biosciences Inc. building a consolidation basePortfolio Return Report & Precise Trade Entry Recommendations - newser.com
Cogent Biosciences Inc. (COGT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Cogent Biosciences stock hits 52-week high at 14.55 USD By Investing.com - Investing.com Nigeria
Cogent Biosciences stock hits 52-week high at 14.55 USD - Investing.com
Platinum Investment Management Ltd. Boosts Stock Position in Cogent Biosciences, Inc. $COGT - MarketBeat
Biotech planning to seek first-ever FDA approval signs new Waltham lease - The Business Journals
Cushman & Wakefield Arranges 31,500-Square-Foot Lease for Cogent Biosciences in Greater Boston - Cushman & Wakefield
Cogent Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Applying big data sentiment scoring on Cogent Biosciences Inc.Weekly Stock Summary & AI Forecast Swing Trade Picks - newser.com
Published on: 2025-09-29 03:19:13 - newser.com
299,200 Stock Options: Cogent Biosciences Strengthens Team with 10 New Hires and Equity Incentives - Stock Titan
Published on: 2025-09-29 00:02:48 - newser.com
Finanzdaten der Cogent Biosciences Inc-Aktie (COGT)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.75%
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):